Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2016

Oct 4, 2016

31971_dirs_2016-10-04_67aab0e7-a948-4234-819c-80ab747d47cc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-09-30

Reporting Person: Lande Jerome J. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-30 Options To Purchase Common Stock $41.06 D 5396 Disposed 2026-06-01 Common Stock (5396) Direct
2016-09-30 Rsus (restricted Stock Units) $0 D 2739 Disposed 2026-06-01 Common Stock (2739) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7000 Direct

Footnotes

F1: At Mr. Lande's request, the Board cancelled his 2016 RSUs and Stock Options. Mr. Lande received no value for the cancellation of these RSUs and Stock Options.

F2: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period.

F3: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period.